Articles

Videos

Podcasts

Clinical

A new cell isolation kit was approved by the FDA to decrease the amount of time needed in a lab and lower overall costs for testing tuberculosis.

FDA Approves T-Cell Select Test for Automated Tuberculosis Testing

Although there is no “best” way to determine which route of administration is best, health care providers are optimally positioned to educate patients and help them make the best decision.

Options for Immunoglobulin Administration Allow for Personalized Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

Asceniv is a plasma-derived polyclonal IVIG drug product designed to prevent serious bacterial infections in patients with primary humoral immunodeficiency disease.

Clinical Overview: Asceniv IVIG for Primary Humoral Immunodeficiency Disease 

Complete recovery of platelet counts after obinutuzumab-based therapy was found to be associated with, or accelerated by, intravenous immunoglobulin.

Intravenous Immunoglobulin May Accelerate Platelet Count Stabilization, Recovery in Obinutuzumab-Related Thrombocytopenia

Though there is no well-defined therapeutic approach to the treatment of Arndt-Gottron syndrome, intravenous immunoglobulins have been documented as a well-tolerated treatment in some cases.

Effective Treatment for Some Patients with Arndt-Gottron Syndrome Can Be Achieved With IVIG

There are several key areas of risk that infusion practices are likely to face at some point, and proactively preparing for these events can help ensure a positive outcome.

Infusion Centers Must Be Proactive to Reduce Risks

The ability of an anti-interleukin-23 antibody to bind to key immune system components may help neutralize a key driver of inflammation right at its cellular source.

New Binding Mechanism Science Driving Therapeutic Insight in Immune-Mediated Diseases

Researchers recommend having a low clinical threshold for the diagnosis of Hashimoto’s encephalopathy in patients who reveal no apparent cause for their altered mental status, given the heterogenous nature of the condition’s presentation.

Plasmapheresis is Viable Treatment Option for Patients with Hashimoto’s Encephalopathy Nonresponsive to Steroids

Patients with past medical histories of immunoglobulin E-mediated hypersensitivity reactions to metronidazole and other antimicrobial agents may receive safe and effective treatment using desensitization protocols.

Study: Metronidazole Desensitization Effectively Treats Patients with Hypersensitivity Reactions

Privigen is indicated for the treatment of primary humoral immunodeficiency, chronic immune thrombocytopenic purpura in patients 15 years of age and older, chronic inflammatory demyelinating polyneuropathy in adults.

Daily Medication Pearl: Privigen Immune Globulin Intravenous (Human)

® IVIG Resource Center is a comprehensive resource for clinical news and expert insights on the use of intravenous immunoglobulin, a product comprised of antibodies administered intravenously.